Abstract

ObjectiveMitochondria have an important role in the induction of the NLRP3 inflammasome response central in gout. The objective was to test whether mitochondrial genetic variation and copy number in New...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
OP0158 Mitochondrial Genetic Variation and Susceptibility To Gout in Polynesians
T.R Merriman ... L Stamp
Annals of the Rheumatic Diseases | VOL. 75
T.R Merriman, et. al.T.R Merriman ... L Stamp
01 Jun 2016
Cancer incidence, mortality and survival for Pacific Peoples in Aotearoa New Zealand.
Jason Gurney ... Ineke Meredith
The New Zealand medical journal | VOL. 136
Jason Gurney, et. al.Jason Gurney ... Ineke Meredith
01 Dec 2023
National prevalence of gout derived from administrative health data in Aotearoa New Zealand.
D Winnard ... C Wright
Rheumatology (Oxford, England) | VOL. 51
D Winnard, et. al.D Winnard ... C Wright
16 Jan 2012
Genome-wide association study of mitochondrial copy number.
Manuel Gentiluomo ... Hermann Brenner
Human Molecular Genetics | VOL. 31
Manuel Gentiluomo, et. al.Manuel Gentiluomo ... Hermann Brenner
23 Nov 2021
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Jinjing Liu ... Xiaofeng Zeng
Annals of the Rheumatic Diseases | VOL. -
Jinjing Liu, et. al.Jinjing Liu ... Xiaofeng Zeng
27 Nov 2024
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
Merav Lidar ... Abraham Avigdor
Annals of the Rheumatic Diseases | VOL. -
Merav Lidar, et. al.Merav Lidar ... Abraham Avigdor
27 Nov 2024
Correction: Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
-
Annals of the Rheumatic Diseases | VOL. -
--
27 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.